Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17494
Country/Region: Côte d'Ivoire
Year: 2016
Main Partner: Health Alliance International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,145,103 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $472,303
Care: Orphans and Vulnerable Children (HKID) $581,058
Care: TB/HIV (HVTB) $268,394
Care: Pediatric Care and Support (PDCS) $121,829
Laboratory Infrastructure (HLAB) $32,000
Testing: HIV Testing and Counseling (HVCT) $377,944
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $593,041
Treatment: Adult Treatment (HTXS) $2,228,156
Treatment: Pediatric Treatment (PDTX) $470,378
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 39
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 142
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 42
GEND_GBV Number of people receiving post-GBV care 2017 184
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 11,870
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 12,825
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 116,114
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 125,407
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 266,216
HTS_TST Service Delivery Point (Community): Index testing 2017 795
HTS_TST Service Delivery Point (Community): Other 2017 2,387
HTS_TST Service Delivery Point (Facility): Inpatient 2017 159,441
HTS_TST Service Delivery Point (Facility): Malnutrition facilities 2017 3,192
HTS_TST Service Delivery Point (Facility): Outpatient 2017 18,751
HTS_TST Service Delivery Point (Facility): PMTCT 2017 79,326
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 2,324
HTS_TST Sum of Aggregated Age/Sex <15 2017 24,695
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 241,521
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 266,216
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 583
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 699
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,740
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 5,118
LAB_PT Early infant diagnostics: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 2
LAB_PT Early infant diagnostics: Number of laboratories that participate in this PT program 2017 2
LAB_PT Early infant diagnostics: Number of laboratories that perform this testing 2017 2
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 233
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 291
LAB_PT HIV viral load: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 2
LAB_PT HIV viral load: Number of laboratories that participate in this PT program 2017 2
LAB_PT HIV viral load: Number of laboratories that perform this testing 2017 2
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 3
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that participate in this PT program 2017 3
LAB_PT TB diagnostics (AFB microscopy): Number of laboratories that perform this testing 2017 27
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that participate in this PT program 2017 1
LAB_PT TB diagnostics (Xpert MTB/RIF): Number of laboratories that perform this testing 2017 1
OVC_SERV Age/Sex: 18+ Female 2017 1,614
OVC_SERV Age/Sex: 18+ Male 2017 1,750
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 3,356
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 3,378
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 10,098
OVC_SERV Sum of Age/Sex disaggregates 2017 3,364
PMTCT_ART Already on ART at beginning of current pregnancy 2017 1,096
PMTCT_ART New on ART 2017 1,068
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 80,270
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,276
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 644
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 34
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 22
PMTCT_EID Sum of Infant Age disaggregates 2017 1,920
PMTCT_STAT By: Known positives at entry 2017 1,070
PMTCT_STAT By: Number of new positives identified 2017 1,147
PMTCT_STAT Number of new ANC and L&D clients 2017 84,453
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 80,270
PMTCT_STAT Sum of Positives Status disaggregates 2017 2,217
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 11
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 355
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 7
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 293
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 666
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 635
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2,736
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 304
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 2,068
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 364
TB_SCREENDX Screen Result: Screened Positive for TB 2017 2,736
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 18,668
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 7,268
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 684
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 702
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 27,322
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 42
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 884
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 69
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,291
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,286
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,434
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,142
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,156
TX_CURR Aggregated Age/Sex: 15+ Female 2017 18,934
TX_CURR Aggregated Age/Sex: 15+ Male 2017 9,552
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 30,784
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,298
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 28,486
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 30,784
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 737
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 767
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 7,261
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,786
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 12,551
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 12,551
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 33,388
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 25,042
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 858
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 887
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 15,489
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 7,808
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,161
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,191
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 20,632
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 10,404
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 97
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 101
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3,222
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,686
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 5,106
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 6,379
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 138
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 139
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4,017
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,085
Cross Cutting Budget Categories and Known Amounts Total: $5,124,169
Human Resources for Health $4,580,761
Renovation $275,000
Motor Vehicles: Purchased $114,000
Gender: Gender Based Violence (GBV) $154,408
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation